MIRA Pharmaceuticals, Inc. (MIRA) stock
MIRANasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 7/30
$0.29−0.08 (-20.99%)
Close on Nov 20, 2026Market cap $12.23MP/E –Yield –
MIRA Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
MIRA Pharmaceuticals's enterprise value was $18.03M on Nov 11, 2026, against $50.94M a year earlier. Over the last 3 years it ranged from $3.53M to $62.62M, with a median of $21.45M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $18.03M | -65.4% |
| 2025 | Dec 31, 2025 | $52.13M | +433.9% |
| 2024 | Dec 31, 2024 | $9.76M | +69.2% |
| 2023 | Dec 29, 2023 | $5.77M | – |
See a number that looks wrong?